SG11201806835SA - Compositions and methods for the treatment of sinus disease and disorders - Google Patents
Compositions and methods for the treatment of sinus disease and disordersInfo
- Publication number
- SG11201806835SA SG11201806835SA SG11201806835SA SG11201806835SA SG11201806835SA SG 11201806835S A SG11201806835S A SG 11201806835SA SG 11201806835S A SG11201806835S A SG 11201806835SA SG 11201806835S A SG11201806835S A SG 11201806835SA SG 11201806835S A SG11201806835S A SG 11201806835SA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- treatment
- methods
- street
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/731—Carrageenans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2016900553A AU2016900553A0 (en) | 2016-02-17 | Compositions and Methods for the Treatment of Sinus Diseases and Disorders | |
| PCT/AU2017/050144 WO2017139854A1 (en) | 2016-02-17 | 2017-02-17 | Compositions and methods for the treatment of sinus disease and disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201806835SA true SG11201806835SA (en) | 2018-09-27 |
Family
ID=59624790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201806835SA SG11201806835SA (en) | 2016-02-17 | 2017-02-17 | Compositions and methods for the treatment of sinus disease and disorders |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11357791B2 (OSRAM) |
| EP (1) | EP3416655A4 (OSRAM) |
| JP (1) | JP2019505538A (OSRAM) |
| KR (1) | KR20180108811A (OSRAM) |
| CN (1) | CN108697731A (OSRAM) |
| AU (1) | AU2017220396B2 (OSRAM) |
| BR (1) | BR112018016651A2 (OSRAM) |
| CA (1) | CA3013942C (OSRAM) |
| HK (1) | HK1258884A1 (OSRAM) |
| IL (1) | IL261134B2 (OSRAM) |
| MY (1) | MY200434A (OSRAM) |
| SG (1) | SG11201806835SA (OSRAM) |
| WO (1) | WO2017139854A1 (OSRAM) |
| ZA (1) | ZA201806103B (OSRAM) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11357791B2 (en) | 2016-02-17 | 2022-06-14 | Ent Technologies Pty Ltd | Compositions and methods for the treatment of sinus disease and disorders |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3563194B2 (ja) * | 1996-03-15 | 2004-09-08 | 株式会社ノエビア | 塩化ナトリウム含有ゲル組成物及びその製造方法 |
| JPH11189533A (ja) * | 1997-12-25 | 1999-07-13 | Taisho Pharmaceut Co Ltd | 点眼薬 |
| US6214376B1 (en) * | 1998-08-25 | 2001-04-10 | Banner Pharmacaps, Inc. | Non-gelatin substitutes for oral delivery capsules, their composition and process of manufacture |
| US6518244B2 (en) * | 2000-03-09 | 2003-02-11 | Intimax Corporation | Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof |
| JP2002302448A (ja) * | 2001-04-02 | 2002-10-18 | Shiseido Co Ltd | 皮膚外用剤 |
| CN1491724A (zh) * | 2003-09-02 | 2004-04-28 | 无锡杰西医药科技有限公司 | 一种适用于青光眼治疗的成胶增稠用多糖系统 |
| EP1930015A1 (en) | 2006-12-05 | 2008-06-11 | Marinomed Biotechnologie GmbH | Use of carrageenan for treating rhinovirus infections |
| US20080317791A1 (en) | 2007-06-25 | 2008-12-25 | Cp Kelco U.S., Inc. | Kappa Carrageenan |
| JP2011219412A (ja) * | 2010-04-09 | 2011-11-04 | Saisentan Igaku Kenkyusho:Kk | 緑内障の視野改善治療薬 |
| WO2012103575A1 (en) | 2011-02-02 | 2012-08-09 | Ent Technologies Pty Ltd | Compositions and methods for the treatment of nasal passages |
| WO2012126777A1 (en) | 2011-03-18 | 2012-09-27 | Marinomed Biotechnologie Gmbh | Inhibition of neuraminidase activity |
| RU2015136769A (ru) | 2013-02-05 | 2017-03-13 | Дзе Попьюлейшн Каунсил, Инк. | Внутривагинальное кольцо для доставки уникальных комбинаций противомикробных композиций |
| CA2932237C (en) * | 2013-12-03 | 2022-12-13 | Gerolymatos International S.A. | Ionic aqueous compositions comprising sulfated polysaccharides |
| EP3099292A1 (en) * | 2014-01-28 | 2016-12-07 | Resdevco Research and Development Co. Ltd. | Composition comprising xylitol and cholecalciferol for topical treatment of skin and mucous membranes |
| DE102015110674A1 (de) | 2015-07-02 | 2017-01-05 | Sms Group Gmbh | Umbausystem für einen Elektrolichtbogenofen (EAF) |
| CN107847430B (zh) * | 2015-07-14 | 2021-02-02 | 玛丽诺姆德生物技术股份公司 | 一种具有抗病毒活性的鼻塞疏通组合物 |
| US11357791B2 (en) | 2016-02-17 | 2022-06-14 | Ent Technologies Pty Ltd | Compositions and methods for the treatment of sinus disease and disorders |
-
2017
- 2017-02-17 US US15/998,565 patent/US11357791B2/en active Active
- 2017-02-17 JP JP2018542227A patent/JP2019505538A/ja active Pending
- 2017-02-17 WO PCT/AU2017/050144 patent/WO2017139854A1/en not_active Ceased
- 2017-02-17 HK HK19101357.4A patent/HK1258884A1/zh unknown
- 2017-02-17 EP EP17752579.7A patent/EP3416655A4/en not_active Withdrawn
- 2017-02-17 KR KR1020187025908A patent/KR20180108811A/ko not_active Withdrawn
- 2017-02-17 AU AU2017220396A patent/AU2017220396B2/en active Active
- 2017-02-17 CN CN201780014521.4A patent/CN108697731A/zh active Pending
- 2017-02-17 BR BR112018016651A patent/BR112018016651A2/pt not_active Application Discontinuation
- 2017-02-17 SG SG11201806835SA patent/SG11201806835SA/en unknown
- 2017-02-17 CA CA3013942A patent/CA3013942C/en active Active
- 2017-02-17 MY MYPI2018702901A patent/MY200434A/en unknown
-
2018
- 2018-08-13 IL IL261134A patent/IL261134B2/en unknown
- 2018-09-12 ZA ZA2018/06103A patent/ZA201806103B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20200276226A1 (en) | 2020-09-03 |
| IL261134A (en) | 2018-10-31 |
| IL261134B2 (en) | 2023-03-01 |
| US11357791B2 (en) | 2022-06-14 |
| MY200434A (en) | 2023-12-26 |
| EP3416655A4 (en) | 2019-11-20 |
| ZA201806103B (en) | 2019-07-31 |
| JP2019505538A (ja) | 2019-02-28 |
| EP3416655A1 (en) | 2018-12-26 |
| BR112018016651A2 (pt) | 2018-12-26 |
| KR20180108811A (ko) | 2018-10-04 |
| WO2017139854A1 (en) | 2017-08-24 |
| CA3013942C (en) | 2024-03-26 |
| AU2017220396B2 (en) | 2022-12-15 |
| AU2017220396A1 (en) | 2018-10-04 |
| HK1258884A1 (zh) | 2019-11-22 |
| CN108697731A (zh) | 2018-10-23 |
| CA3013942A1 (en) | 2017-08-24 |
| IL261134B (en) | 2022-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201809751XA (en) | Egfr inhibitor compounds | |
| SG11201908719QA (en) | Biomarkers and car t cell therapies with enhanced efficacy | |
| SG11201909949XA (en) | Targeted immunotolerance | |
| SG11201803728YA (en) | Topical pharmaceutical formulations for treating inflammatory-related conditions | |
| SG11201803920TA (en) | Compounds and compositions useful for treating disorders related to ntrk | |
| SG11201903882VA (en) | Il-2 variants for the treatment of autoimmune diseases | |
| SG11201909963YA (en) | Methods for treating dravet syndrome | |
| SG11201808990QA (en) | Compositions for topical application of compounds | |
| SG11201908743SA (en) | Methods and compositions for modulation of immune cells | |
| SG11201805709RA (en) | Anti-pro/latent myostatin antibodies and methods of use thereof | |
| SG11201808125RA (en) | Methods for solid tumor treatment | |
| SG11201900501RA (en) | Cannabis composition | |
| SG11201908056QA (en) | Anti-par2 antibodies and uses thereof | |
| SG11201900554YA (en) | Spiro-lactam nmda modulators and methods of using same | |
| SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
| SG11201901063SA (en) | Therapeutic agents for neurodegenerative diseases | |
| SG11201804673WA (en) | Novel anti-claudin antibodies and methods of use | |
| SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
| SG11201900558RA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201807255YA (en) | Treatment of autoimmune diseases with combinations of rxr agonists and thyroid hormones | |
| SG11201900551WA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201901228QA (en) | Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide | |
| SG11201900546UA (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201803816RA (en) | Targeting of the formyl-peptide receptor 2/lipoxin a4 receptor (fpr2/alx) for treatment of heart disease | |
| SG11201906778RA (en) | Improved methods for assessing risk of developing breast cancer |